Japanese drugmaker Eisai today revealed that it has launched its Urece (dotinurad) in China as a treatment for gout. Urece ...

URECE is a new therapeutic medicine for gout and hyperuricemia discovered by FUJI YAKUHIN. It suppresses uric acid reabsorption and lowers blood uric acid levels by selectively inhibiting the urate ...

The mechanism for the renal handling of uric acid, according to recent evidence well summarized by Gutman et al., 24 involves virtually complete reabsorption of all the urate that is filtered at ...

The urate transporter 1 (URAT1) is the primary urate transporter in the kidney responsible for urate reabsorption and, therefore, is crucial for urate homeostasis. Hyperuricemia causes the common ...

Gout is a type of arthritis caused by excess urate levels, a byproduct of purine metabolism. URAT1 is a transporter that regulates urate levels, controlling its reabsorption in the kidneys. Despite ...

Gout is a type of arthritis caused by excess urate levels, a byproduct of purine metabolism. URAT1 is a transporter that regulates urate levels, controlling its reabsorption in the kidneys.

Gout is a type of arthritis caused by excess urate levels, a byproduct of purine metabolism. URAT1 is a transporter that regulates urate levels, controlling its reabsorption in the kidneys.

While it might be surprising to you, certain popular medications can increase uric acid and trigger gout symptoms. You may ...

Dotinurad is a novel, selective urate reabsorption inhibitor approved in 2020 for treating hyperuricemia and gout in Japan. The drug lowers serum uric acid levels by selectively inhibiting the urate ...